Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Petter Bjornstad

Concepts (454)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Nephropathies
92
2026
320
26.620
Why?
Diabetes Mellitus, Type 2
83
2026
2623
11.580
Why?
Diabetes Mellitus, Type 1
86
2026
3930
10.320
Why?
Glomerular Filtration Rate
73
2026
745
9.250
Why?
Kidney
60
2026
1498
7.360
Why?
Insulin Resistance
25
2026
1247
5.270
Why?
Renal Insufficiency, Chronic
30
2026
640
4.920
Why?
Uric Acid
23
2022
167
4.370
Why?
Albuminuria
24
2026
190
4.160
Why?
Biomarkers
42
2026
4340
2.970
Why?
Sodium-Glucose Transporter 2
14
2026
29
2.950
Why?
Cardiovascular Diseases
19
2026
2219
2.780
Why?
Bariatric Surgery
6
2026
250
2.710
Why?
Pediatric Obesity
9
2025
635
2.700
Why?
Hemodynamics
23
2025
1114
2.630
Why?
Metformin
12
2025
328
2.610
Why?
Hypoglycemic Agents
28
2026
1412
2.570
Why?
Renal Insufficiency
6
2023
173
2.530
Why?
Coronary Artery Disease
11
2022
751
2.360
Why?
Diabetic Angiopathies
9
2019
265
2.280
Why?
Glucosides
15
2026
56
2.260
Why?
Benzhydryl Compounds
15
2026
81
2.210
Why?
Glycopeptides
10
2021
48
2.090
Why?
Adolescent
71
2026
22557
2.020
Why?
Vascular Calcification
6
2022
109
2.010
Why?
Obesity, Morbid
5
2020
287
1.950
Why?
Humans
203
2026
146342
1.890
Why?
Renin-Angiotensin System
10
2021
80
1.820
Why?
Kidney Diseases
4
2025
428
1.750
Why?
Creatinine
21
2026
511
1.660
Why?
Disease Progression
26
2026
2867
1.530
Why?
Male
124
2026
73396
1.530
Why?
Young Adult
48
2026
14330
1.520
Why?
Sex Characteristics
7
2025
801
1.500
Why?
Female
119
2026
79499
1.430
Why?
Glucagon-Like Peptides
4
2026
76
1.360
Why?
Diabetic Ketoacidosis
4
2025
212
1.350
Why?
Obesity
15
2026
3131
1.350
Why?
Calcinosis
4
2015
231
1.230
Why?
Blood Glucose
17
2026
2360
1.220
Why?
Risk Factors
40
2026
10921
1.210
Why?
Adult
67
2026
41087
1.160
Why?
Child
40
2026
22693
1.100
Why?
Diabetic Cardiomyopathies
4
2020
34
1.090
Why?
Mechanistic Target of Rapamycin Complex 1
2
2026
141
1.050
Why?
Follow-Up Studies
22
2026
5439
1.020
Why?
Adiposity
6
2025
533
1.010
Why?
Hyperglycemia
6
2025
384
0.990
Why?
Kidney Glomerulus
7
2026
129
0.960
Why?
Middle Aged
65
2026
36619
0.950
Why?
Hypertension
9
2021
1272
0.940
Why?
Cardio-Renal Syndrome
1
2026
20
0.940
Why?
Janus Kinases
1
2026
21
0.920
Why?
STAT Transcription Factors
1
2026
25
0.920
Why?
Prognosis
17
2026
4351
0.920
Why?
Arterioles
3
2024
52
0.910
Why?
Proteinuria
3
2026
103
0.910
Why?
Acute Kidney Injury
6
2025
866
0.900
Why?
Atherosclerosis
4
2018
410
0.900
Why?
Body Composition
4
2026
689
0.900
Why?
Exercise Tolerance
3
2017
289
0.880
Why?
Vascular Stiffness
7
2022
488
0.870
Why?
Fructose
4
2021
132
0.870
Why?
Apolipoproteins B
2
2015
48
0.870
Why?
Uromodulin
3
2019
22
0.850
Why?
Hyperuricemia
6
2021
47
0.840
Why?
Vasopressins
3
2023
60
0.830
Why?
Iohexol
3
2025
23
0.830
Why?
Adiponectin
2
2016
243
0.820
Why?
Immunoglobulin Fc Fragments
1
2024
41
0.820
Why?
Cross-Sectional Studies
19
2025
5899
0.820
Why?
Case-Control Studies
14
2025
3647
0.820
Why?
Iothalamic Acid
1
2022
5
0.750
Why?
Kidney Tubules
2
2021
117
0.750
Why?
Dyslipidemias
5
2021
184
0.740
Why?
Kidney Failure, Chronic
5
2026
589
0.740
Why?
Blood Pressure
10
2025
1765
0.740
Why?
Diabetic Retinopathy
4
2021
211
0.730
Why?
Prediabetic State
1
2025
250
0.720
Why?
Cystatin C
8
2023
65
0.720
Why?
Epithelial-Mesenchymal Transition
1
2024
219
0.710
Why?
Epidermal Growth Factor
4
2026
157
0.710
Why?
Hyperoxia
1
2024
126
0.710
Why?
Recombinant Fusion Proteins
1
2024
663
0.680
Why?
Bone Density
1
2025
494
0.660
Why?
Polycystic Kidney, Autosomal Dominant
1
2024
244
0.640
Why?
Podocytes
3
2026
80
0.620
Why?
Kidney Function Tests
7
2026
156
0.620
Why?
Fasting
3
2026
280
0.620
Why?
Oxygen Consumption
3
2017
721
0.610
Why?
Triglycerides
3
2022
527
0.600
Why?
Insulin
11
2026
2525
0.590
Why?
Pilot Projects
8
2026
1888
0.590
Why?
Vascular Resistance
6
2020
365
0.590
Why?
Mitochondria
1
2026
997
0.590
Why?
Dried Blood Spot Testing
2
2018
129
0.580
Why?
Endothelial Cells
4
2026
876
0.580
Why?
Cyclic GMP
1
2019
88
0.580
Why?
Incidence
11
2026
2936
0.580
Why?
Oxygen
2
2024
997
0.570
Why?
Lipid Metabolism Disorders
1
2018
4
0.570
Why?
Coronary Vessels
3
2017
245
0.560
Why?
Longevity
6
2022
179
0.560
Why?
Aged
40
2026
26432
0.560
Why?
Cardiotonic Agents
1
2018
96
0.550
Why?
Gastric Bypass
1
2020
115
0.550
Why?
Leptin
2
2017
248
0.540
Why?
Cohort Studies
18
2025
6077
0.540
Why?
Hemofiltration
1
2018
24
0.540
Why?
Weight Reduction Programs
1
2019
140
0.530
Why?
Overweight
3
2025
614
0.530
Why?
Sodium Bicarbonate
1
2018
48
0.530
Why?
Cholesterol, HDL
2
2015
201
0.520
Why?
Blood Vessels
1
2018
164
0.510
Why?
Ventricular Function, Left
3
2020
541
0.510
Why?
Glucose
5
2023
1053
0.510
Why?
Inflammation
3
2026
2919
0.490
Why?
Canagliflozin
4
2026
11
0.490
Why?
Aorta
2
2019
440
0.480
Why?
Up-Regulation
2
2016
841
0.480
Why?
Nutrition Surveys
1
2017
270
0.470
Why?
Cholesterol, LDL
2
2014
363
0.460
Why?
Testosterone
4
2026
419
0.460
Why?
Glucose Clamp Technique
7
2026
199
0.450
Why?
Body Mass Index
10
2026
2458
0.440
Why?
Drug Therapy, Combination
6
2025
1036
0.430
Why?
Renal Circulation
3
2021
75
0.430
Why?
Angiotensin II Type 2 Receptor Blockers
1
2014
7
0.420
Why?
Canada
7
2022
432
0.420
Why?
Nephrotic Syndrome
2
2026
44
0.410
Why?
Sodium
5
2025
196
0.410
Why?
Gastrectomy
2
2026
164
0.400
Why?
Natriuresis
3
2025
13
0.400
Why?
Signal Transduction
3
2026
5246
0.400
Why?
Echocardiography
2
2018
645
0.400
Why?
Pregnancy Outcome
1
2017
503
0.400
Why?
Dietary Supplements
1
2018
587
0.390
Why?
Hypoxia
2
2020
1211
0.390
Why?
Estradiol
3
2026
517
0.390
Why?
Goals
1
2015
187
0.380
Why?
Vasoconstriction
3
2020
216
0.380
Why?
Patient Care Planning
1
2014
170
0.370
Why?
Glucagon-Like Peptide 1
5
2026
150
0.370
Why?
Chitinase-3-Like Protein 1
2
2022
18
0.370
Why?
Brain
1
2025
2991
0.360
Why?
Heart Failure
3
2021
2329
0.360
Why?
Clinical Trials as Topic
7
2025
1064
0.360
Why?
Histidine
2
2022
67
0.350
Why?
Contrast Media
1
2015
493
0.350
Why?
Double-Blind Method
7
2026
2070
0.350
Why?
Age of Onset
2
2025
558
0.340
Why?
Prospective Studies
11
2026
8123
0.340
Why?
Lipids
2
2022
714
0.330
Why?
Proteome
2
2026
520
0.330
Why?
Albumins
3
2022
120
0.330
Why?
Angiotensin II
3
2020
102
0.320
Why?
Guideline Adherence
1
2015
594
0.310
Why?
Absorptiometry, Photon
2
2025
278
0.310
Why?
Lipocalin-2
2
2022
80
0.310
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
449
0.310
Why?
Precision Medicine
2
2026
462
0.290
Why?
Animals
19
2026
38106
0.290
Why?
Energy Metabolism
2
2026
930
0.290
Why?
Linagliptin
2
2026
5
0.280
Why?
Pulse Wave Analysis
5
2022
268
0.280
Why?
Running
2
2023
235
0.280
Why?
Biopsy
4
2026
1075
0.270
Why?
Treatment Outcome
12
2026
11821
0.270
Why?
Diabetes Complications
2
2021
219
0.260
Why?
Magnetic Resonance Imaging
6
2025
3926
0.250
Why?
Metabolic Syndrome
3
2021
364
0.250
Why?
Time Factors
7
2025
7109
0.250
Why?
Clusterin
1
2026
11
0.240
Why?
Sex Factors
5
2025
2107
0.240
Why?
Dipeptidyl-Peptidase IV Inhibitors
3
2025
46
0.240
Why?
Randomized Controlled Trials as Topic
5
2026
1763
0.240
Why?
MEF2 Transcription Factors
1
2026
51
0.240
Why?
Diet, Carbohydrate-Restricted
1
2026
36
0.240
Why?
Heat Stress Disorders
2
2018
84
0.240
Why?
Glucagon-Like Peptide-1 Receptor
3
2021
88
0.230
Why?
Age Factors
7
2019
3347
0.230
Why?
Severity of Illness Index
3
2021
2921
0.230
Why?
Diabetes Mellitus
3
2021
1101
0.230
Why?
Hydrogen-Ion Concentration
2
2018
533
0.220
Why?
Gliclazide
1
2025
2
0.220
Why?
Colorado
4
2017
4595
0.220
Why?
Abdominal Fat
1
2025
51
0.220
Why?
Osmolar Concentration
3
2026
165
0.220
Why?
Leucine
2
2024
116
0.220
Why?
Fatty Acid Binding Protein 3
1
2024
6
0.220
Why?
Early Diagnosis
2
2017
251
0.210
Why?
Vascular Cell Adhesion Molecule-1
1
2024
42
0.210
Why?
Predictive Value of Tests
4
2018
2113
0.210
Why?
Citric Acid Cycle
1
2024
58
0.210
Why?
Renin
2
2022
33
0.210
Why?
Diuretics
2
2023
66
0.210
Why?
Androgen Antagonists
1
2025
91
0.210
Why?
Gray Matter
1
2025
96
0.210
Why?
Lipoproteins
2
2022
165
0.210
Why?
Endothelin Receptor Antagonists
2
2024
60
0.200
Why?
Blood Proteins
1
2026
239
0.200
Why?
Consensus
2
2022
467
0.200
Why?
Gonadal Steroid Hormones
1
2024
143
0.190
Why?
Receptors, Vasopressin
2
2021
20
0.190
Why?
Mineralocorticoid Receptor Antagonists
2
2024
69
0.190
Why?
Extracellular Vesicles
1
2026
176
0.190
Why?
Inappropriate ADH Syndrome
1
2023
7
0.190
Why?
Nephrosis, Lipoid
1
2023
11
0.190
Why?
National Institutes of Health (U.S.)
1
2024
147
0.190
Why?
Cysts
1
2024
108
0.190
Why?
Membrane Glycoproteins
1
2026
495
0.190
Why?
Fluorocarbons
1
2024
122
0.190
Why?
Pancreas
1
2025
343
0.190
Why?
Hyponatremia
1
2023
42
0.190
Why?
Single-Cell Analysis
1
2026
370
0.180
Why?
Transcriptome
2
2026
1068
0.180
Why?
Malates
1
2022
8
0.180
Why?
Fumarates
1
2022
10
0.180
Why?
Threonine
1
2022
43
0.180
Why?
Iodine Radioisotopes
1
2022
139
0.180
Why?
Longitudinal Studies
5
2024
3017
0.180
Why?
Carboxylic Acids
1
2022
32
0.180
Why?
Diabetes Mellitus, Experimental
1
2023
198
0.180
Why?
Pathology, Clinical
1
2022
29
0.180
Why?
Phenylalanine
1
2022
69
0.170
Why?
Rats
2
2024
5586
0.170
Why?
Heart
1
2025
626
0.170
Why?
Amino Acids
2
2024
515
0.170
Why?
Patient Participation
1
2025
457
0.170
Why?
Chemokine CCL2
1
2022
112
0.170
Why?
Arizona
1
2021
81
0.170
Why?
Health Status Disparities
1
2024
322
0.170
Why?
Weight Loss
3
2026
858
0.170
Why?
Glycine
1
2022
184
0.160
Why?
Risk Assessment
6
2026
3712
0.160
Why?
Mice
7
2026
18297
0.160
Why?
Oxidation-Reduction
1
2024
1075
0.160
Why?
p-Aminohippuric Acid
1
2020
5
0.160
Why?
Image Processing, Computer-Assisted
1
2025
778
0.160
Why?
Tryptophan
1
2022
184
0.160
Why?
Interleukin-18
1
2022
234
0.160
Why?
Multivariate Analysis
2
2014
1543
0.160
Why?
Nephrosis
1
2020
6
0.160
Why?
Furosemide
1
2020
37
0.160
Why?
Natriuretic Peptide, Brain
1
2021
110
0.160
Why?
Asymptomatic Diseases
2
2019
102
0.160
Why?
Japan
5
2017
149
0.160
Why?
Clinical Trials, Phase III as Topic
3
2025
116
0.150
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2024
228
0.150
Why?
Diabetic Neuropathies
1
2021
101
0.150
Why?
Machine Learning
1
2026
594
0.150
Why?
Calcium Channel Blockers
1
2021
165
0.150
Why?
Sodium-Glucose Transporter 1
1
2019
11
0.150
Why?
Transgender Persons
1
2023
213
0.150
Why?
Body Water
1
2019
23
0.150
Why?
Diabetic Foot
1
2019
25
0.150
Why?
Models, Biological
3
2016
1761
0.150
Why?
Oxidative Stress
1
2026
1369
0.150
Why?
Glycolysis
1
2021
342
0.150
Why?
Multicenter Studies as Topic
3
2025
417
0.150
Why?
Glomerulonephritis
1
2019
46
0.150
Why?
Glycosides
1
2019
43
0.140
Why?
Blood Chemical Analysis
1
2019
109
0.140
Why?
Postmenopause
1
2021
394
0.140
Why?
beta 2-Microglobulin
1
2018
47
0.140
Why?
Software
2
2025
676
0.140
Why?
Myocardial Contraction
1
2020
292
0.140
Why?
Proof of Concept Study
3
2025
90
0.140
Why?
Carotid Intima-Media Thickness
1
2018
75
0.140
Why?
Cell Proliferation
1
2026
2502
0.140
Why?
Body Temperature Regulation
1
2019
106
0.140
Why?
Microscopy, Polarization
1
2018
30
0.140
Why?
Pharmaceutical Preparations
1
2020
172
0.140
Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
42
0.130
Why?
Allopurinol
1
2018
70
0.130
Why?
Obesity, Metabolically Benign
1
2017
4
0.130
Why?
Child, Preschool
4
2025
11913
0.130
Why?
Prehypertension
1
2017
27
0.130
Why?
Glucose Tolerance Test
2
2019
360
0.130
Why?
Glomerulosclerosis, Focal Segmental
1
2017
43
0.130
Why?
Hyperthermia, Induced
1
2018
119
0.120
Why?
Urinary Calculi
1
2017
10
0.120
Why?
Deamino Arginine Vasopressin
1
2016
15
0.120
Why?
Peptide Fragments
1
2021
693
0.120
Why?
Ventricular Dysfunction, Left
1
2020
391
0.120
Why?
Life Style
1
2019
496
0.120
Why?
Magnetic Resonance Angiography
1
2018
249
0.120
Why?
Morbidity
1
2017
319
0.120
Why?
Blood Banks
1
2016
50
0.120
Why?
Dehydration
1
2016
59
0.120
Why?
Regional Blood Flow
1
2018
507
0.120
Why?
Vasodilation
1
2020
519
0.120
Why?
Cardiorespiratory Fitness
1
2017
73
0.120
Why?
Gastrointestinal Microbiome
1
2024
769
0.120
Why?
Anti-Inflammatory Agents
1
2020
474
0.120
Why?
Tomography, X-Ray Computed
2
2018
2786
0.120
Why?
Disease Models, Animal
5
2021
4580
0.120
Why?
Vitreoretinopathy, Proliferative
1
2016
15
0.120
Why?
Linear Models
2
2017
857
0.120
Why?
Logistic Models
3
2017
2126
0.120
Why?
Survival Rate
2
2017
2092
0.110
Why?
Heart Rate
1
2019
846
0.110
Why?
Cognition
1
2024
1292
0.110
Why?
Echocardiography, Doppler
1
2016
117
0.110
Why?
Hot Temperature
1
2018
396
0.110
Why?
Gene Expression Regulation
2
2026
2599
0.110
Why?
Filtration
1
2015
68
0.110
Why?
Liver Diseases
1
2018
304
0.110
Why?
Apolipoproteins
1
2014
38
0.110
Why?
Integrin beta1
2
2026
31
0.110
Why?
Enzyme Inhibitors
1
2018
823
0.100
Why?
Blood Pressure Determination
1
2015
143
0.100
Why?
Purines
1
2015
188
0.100
Why?
Phenotype
1
2022
3206
0.100
Why?
Achievement
1
2014
58
0.100
Why?
Peptides
3
2026
992
0.100
Why?
Stress, Mechanical
1
2016
497
0.100
Why?
Retrospective Studies
9
2026
17438
0.100
Why?
Immunity, Innate
1
2019
844
0.100
Why?
Gene Regulatory Networks
2
2026
319
0.100
Why?
Liver
2
2021
1864
0.100
Why?
Fatty Acids
2
2026
460
0.090
Why?
Primary Prevention
1
2015
222
0.090
Why?
Exercise Test
1
2016
637
0.090
Why?
Research Design
1
2019
1143
0.090
Why?
Adenosine Triphosphate
1
2015
494
0.090
Why?
Cholesterol
1
2014
411
0.090
Why?
Biomechanical Phenomena
1
2016
874
0.090
Why?
Cross-Over Studies
2
2026
615
0.090
Why?
United States
3
2024
16136
0.090
Why?
Antihypertensive Agents
1
2016
519
0.090
Why?
Regression Analysis
1
2014
999
0.090
Why?
RNA, Messenger
1
2019
2791
0.080
Why?
Aged, 80 and over
3
2018
8391
0.080
Why?
Vascular Diseases
1
2013
252
0.080
Why?
Feasibility Studies
1
2015
1135
0.080
Why?
Hematocrit
2
2021
108
0.080
Why?
Exercise
1
2022
2213
0.080
Why?
Societies, Medical
1
2015
907
0.080
Why?
Ambulatory Care
1
2015
628
0.080
Why?
Practice Guidelines as Topic
1
2017
1591
0.070
Why?
Proteomics
2
2026
1203
0.070
Why?
Fructokinases
2
2021
42
0.070
Why?
Registries
1
2016
2400
0.060
Why?
Prevalence
3
2019
2861
0.060
Why?
Reproducibility of Results
1
2015
3416
0.060
Why?
Fibrosis
2
2021
568
0.060
Why?
Mesangial Cells
1
2026
4
0.060
Why?
Clinical Trials, Phase II as Topic
1
2026
74
0.060
Why?
Mice, Knockout
2
2026
3125
0.060
Why?
Peptide YY
1
2026
28
0.060
Why?
Infant
2
2025
10114
0.060
Why?
Receptors, Complement
1
2026
126
0.060
Why?
Nephrectomy
1
2026
172
0.050
Why?
C-Peptide
1
2026
191
0.050
Why?
Transforming Growth Factor beta1
1
2026
176
0.050
Why?
Organ Size
1
2025
465
0.050
Why?
Living Donors
1
2026
216
0.050
Why?
Postprandial Period
1
2025
114
0.050
Why?
United Kingdom
1
2025
377
0.050
Why?
Isoleucine
1
2024
15
0.050
Why?
Propensity Score
1
2026
376
0.050
Why?
Pregnancy
1
2017
7230
0.050
Why?
Cell Communication
1
2026
327
0.050
Why?
Valine
1
2024
84
0.050
Why?
Obesity, Abdominal
1
2024
48
0.050
Why?
Doxorubicin
1
2026
416
0.050
Why?
Mice, Inbred C57BL
3
2021
6034
0.050
Why?
Bromocriptine
1
2022
31
0.050
Why?
Antibodies
1
2025
400
0.050
Why?
Environmental Pollutants
1
2024
143
0.050
Why?
Tandem Mass Spectrometry
1
2026
576
0.050
Why?
RNA, Transfer
1
2024
142
0.050
Why?
Aging
1
2014
1996
0.050
Why?
Benzbromarone
1
2022
1
0.050
Why?
Cytokines
2
2021
2081
0.050
Why?
Infant, Newborn
1
2014
6460
0.050
Why?
Aldosterone
1
2022
42
0.040
Why?
NF-kappa B
1
2026
674
0.040
Why?
Glycoproteins
1
2024
356
0.040
Why?
Controlled Clinical Trials as Topic
1
2021
26
0.040
Why?
Tumor Necrosis Factor-alpha
1
2026
1224
0.040
Why?
Inulin
1
2021
12
0.040
Why?
Adenine
1
2023
339
0.040
Why?
Hep G2 Cells
1
2021
74
0.040
Why?
Drinking
1
2021
44
0.040
Why?
Serum Albumin
1
2021
147
0.040
Why?
Uricosuric Agents
1
2020
2
0.040
Why?
Insulin Infusion Systems
1
2026
488
0.040
Why?
Diuretics, Osmotic
1
2020
2
0.040
Why?
Cell Hypoxia
1
2021
249
0.040
Why?
Mendelian Randomization Analysis
1
2020
68
0.040
Why?
TOR Serine-Threonine Kinases
1
2023
455
0.040
Why?
Chemokines
1
2021
217
0.040
Why?
Environmental Exposure
1
2024
578
0.040
Why?
Diastole
1
2020
147
0.040
Why?
Systole
1
2020
179
0.040
Why?
Cytoprotection
1
2019
55
0.040
Why?
Netherlands
1
2019
85
0.040
Why?
Models, Theoretical
1
2023
561
0.040
Why?
Recurrence
1
2023
1133
0.040
Why?
Lipopolysaccharides
1
2023
861
0.040
Why?
Drug Interactions
1
2021
405
0.040
Why?
Preoperative Period
1
2019
157
0.040
Why?
Neuropsychological Tests
1
2024
1149
0.040
Why?
Gene Expression Profiling
1
2026
1792
0.040
Why?
Length of Stay
1
2025
1358
0.040
Why?
Magnetic Resonance Imaging, Cine
1
2020
214
0.030
Why?
Critical Illness
1
2025
908
0.030
Why?
Incretins
1
2018
21
0.030
Why?
Renal Elimination
1
2018
5
0.030
Why?
Macular Edema
1
2018
49
0.030
Why?
Inflammation Mediators
1
2021
508
0.030
Why?
Glucagon-Like Peptide-2 Receptor
1
2018
16
0.030
Why?
Photography
1
2018
120
0.030
Why?
Xanthine Oxidase
1
2018
79
0.030
Why?
HSP70 Heat-Shock Proteins
1
2018
76
0.030
Why?
Cognitive Dysfunction
1
2024
481
0.030
Why?
Diet Therapy
1
2018
36
0.030
Why?
Cardiovascular System
1
2019
137
0.030
Why?
Renal Dialysis
1
2021
461
0.030
Why?
Blood Pressure Monitoring, Ambulatory
1
2017
69
0.030
Why?
Lipoproteins, LDL
1
2017
119
0.030
Why?
Anti-Obesity Agents
1
2018
67
0.030
Why?
Renal Plasma Flow, Effective
1
2016
1
0.030
Why?
Blood Urea Nitrogen
1
2016
53
0.030
Why?
Thiazolidinediones
1
2018
142
0.030
Why?
Aldehyde Reductase
1
2016
31
0.030
Why?
Telemedicine
1
2026
966
0.030
Why?
Water-Electrolyte Balance
1
2016
37
0.030
Why?
Infusions, Intravenous
1
2018
432
0.030
Why?
Interleukin-6
1
2021
784
0.030
Why?
Ammonia
1
2016
61
0.030
Why?
Tomography, Optical Coherence
1
2018
283
0.030
Why?
Age Distribution
1
2017
399
0.030
Why?
Sex Distribution
1
2017
382
0.030
Why?
Proportional Hazards Models
1
2019
1331
0.030
Why?
Collagen
1
2018
460
0.030
Why?
Waist Circumference
1
2015
142
0.030
Why?
Combined Modality Therapy
1
2018
1271
0.030
Why?
Blood Glucose Self-Monitoring
1
2019
704
0.020
Why?
Complement Activation
1
2016
412
0.020
Why?
Circadian Rhythm
1
2017
515
0.020
Why?
Exercise Therapy
1
2018
488
0.020
Why?
Heart Ventricles
1
2018
762
0.020
Why?
Gene-Environment Interaction
1
2014
190
0.020
Why?
Comorbidity
1
2017
1665
0.020
Why?
Rats, Sprague-Dawley
1
2017
2537
0.020
Why?
Models, Statistical
1
2015
669
0.020
Why?
Databases, Factual
1
2017
1493
0.020
Why?
Non-alcoholic Fatty Liver Disease
1
2014
265
0.020
Why?
Algorithms
1
2015
1849
0.020
Why?
Hospitalization
1
2017
2475
0.020
Why?
Neoplasms
1
2014
2954
0.010
Why?
Bjornstad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)